https://www.selleckchem.com/pr....oducts/(-)-Epigalloc
1) than with MPT-RFA (1.3) (P = 0.004). The major complication rates were similar with MPT-RFA (5.8%) and MPT-MWA (2.7%) (P = 0.391). The one-year local tumor progression rate was similar between MPT-RFA (0%) and MPT-MWA (0%) (P = 0.73). MPT-MWA may have improved therapeutic efficiency in the treatment of small HCCs. MPT-MWA may have improved therapeutic efficiency in the treatment of small HCCs. Adherence to a treatment plan from HIV-positive patients is necessary to decrease their mortality and improve their quali
Like
Comment
Share
